Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Cisatracurium Besylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 36,786Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hainan Poly`s Generics Cisatracurium Besylate Receives Approval in US
    Hainan Poly`s Generics Cisatracurium Besylate Receives Approval in US

    27 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216539

    FDA
    27 Aug 2024
    Share Share
    Hainan Poly`s Generic Cisatracurium Besylate Receives Approval in the U.S.
    Hainan Poly`s Generic Cisatracurium Besylate Receives Approval in the U.S.

    08 Mar 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216538

    FDA
    08 Mar 2024
    Share Share
    Caplin's Generic Cisatracurium Besylate Receives Approval in the U.S.
    Caplin's Generic Cisatracurium Besylate Receives Approval in the U.S.

    09 Jun 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217725

    FDA
    09 Jun 2023
    Share Share
    Development Of Manufacturing Technology For Three Pharmaceutical Ingredients
    Development Of Manufacturing Technology For Three Pharmaceutical Ingredients

    30 Jan 2023

    // PRESS RELEASE

    http://cfpharma.hu/development-of-manufacturing-technology-for-three-pharmaceutical-ingredients/

    PRESS RELEASE
    30 Jan 2023
    Share Share
    Piramal's Generic Cisatracurium Besylate Receives Approval in the U.S.
    Piramal's Generic Cisatracurium Besylate Receives Approval in the U.S.

    11 Mar 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212432

    FDA
    11 Mar 2022
    Share Share
    Enforcement Report - Week of March 3, 2021
    Enforcement Report - Week of March 3, 2021

    03 Mar 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-3-2021-1614760051.pdf

    FDA
    03 Mar 2021
    Share Share